Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.77 Million ≈ $6.41 Million USD) by net assets (CN¥2.26 Billion ≈ $330.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceut to measure how many days the company can operate on defensive assets alone.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Swissquote Group Holding SA SW:SQN	0.300x
China Fortune Land Development Co Ltd SHG:600340	0.076x
Shenzhen Hirisun Technology Inc SHE:300277	0.060x
Jiangsu Huaxicun Co Ltd SHE:000936	0.013x
Baotailong New Materials Co Ltd SHG:601011	-0.012x
Hwang Chang General Contractor Co Ltd TW:2543	0.032x
Orrstown Financial Services Inc NASDAQ:ORRF	0.039x
Fujian Raynen Tech Co Ltd SHG:603933	0.037x

Annual Cash Flow Conversion Efficiency for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.12 Billion ≈ $309.74 Million	CN¥141.40 Million ≈ $20.69 Million	0.067x	+1142.58%
2024-12-31	CN¥2.31 Billion ≈ $337.33 Million	CN¥-14.77 Million ≈ $-2.16 Million	-0.006x	-121.28%
2023-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥71.02 Million ≈ $10.39 Million	0.030x	-58.95%
2022-12-31	CN¥2.25 Billion ≈ $329.69 Million	CN¥165.27 Million ≈ $24.18 Million	0.073x	-40.27%
2021-12-31	CN¥2.19 Billion ≈ $320.41 Million	CN¥268.90 Million ≈ $39.35 Million	0.123x	+118.28%
2020-12-31	CN¥2.01 Billion ≈ $293.91 Million	CN¥113.00 Million ≈ $16.54 Million	0.056x	-80.50%
2019-12-31	CN¥933.15 Million ≈ $136.55 Million	CN¥269.23 Million ≈ $39.40 Million	0.289x	+64.76%
2018-12-31	CN¥993.28 Million ≈ $145.35 Million	CN¥173.94 Million ≈ $25.45 Million	0.175x	+265.92%
2017-12-31	CN¥892.48 Million ≈ $130.60 Million	CN¥42.71 Million ≈ $6.25 Million	0.048x	-70.28%
2016-12-31	CN¥873.05 Million ≈ $127.76 Million	CN¥140.57 Million ≈ $20.57 Million	0.161x	+28.05%
2015-12-31	CN¥765.84 Million ≈ $112.07 Million	CN¥96.30 Million ≈ $14.09 Million	0.126x	-3.74%
2014-12-31	CN¥676.42 Million ≈ $98.98 Million	CN¥88.36 Million ≈ $12.93 Million	0.131x	-17.35%
2013-12-31	CN¥565.92 Million ≈ $82.81 Million	CN¥89.44 Million ≈ $13.09 Million	0.158x	-62.69%
2012-12-31	CN¥260.11 Million ≈ $38.06 Million	CN¥110.19 Million ≈ $16.12 Million	0.424x	+71.76%
2011-12-31	CN¥201.07 Million ≈ $29.42 Million	CN¥49.59 Million ≈ $7.26 Million	0.247x	+685.36%
2010-12-31	CN¥168.71 Million ≈ $24.69 Million	CN¥-7.11 Million ≈ $-1.04 Million	-0.042x	-191.84%
2009-12-31	CN¥168.37 Million ≈ $24.64 Million	CN¥7.72 Million ≈ $1.13 Million	0.046x	+121.91%
2008-12-31	CN¥75.88 Million ≈ $11.10 Million	CN¥-15.89 Million ≈ $-2.33 Million	-0.209x	+13.44%
2007-12-31	CN¥71.04 Million ≈ $10.40 Million	CN¥-17.18 Million ≈ $-2.51 Million	-0.242x	-14.96%
2006-12-31	CN¥101.70 Million ≈ $14.88 Million	CN¥-21.40 Million ≈ $-3.13 Million	-0.210x	--

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

SHG:688505 China Drug Manufacturers - Specialty & Generic

Market Cap

$734.50 Million

CN¥5.02 Billion CNY

Market Cap Rank

#10459 Global

#2876 in China

Share Price

CN¥7.14

Change (1 day)

+5.62%

52-Week Range

CN¥6.68 - CN¥11.12

All Time High

CN¥39.80